Coverage of diarrhoea-associated Escherichia coli isolates from different origins with two types of phage cocktails

Microbial Biotechnology

Volumn 7, Issue 2, 2014, Pages 165-176

  Bourdin, Gilles ^a   Navarro, Armando ^b   Sarker, Shafiqul A ^c   Pittet, Anne C ^a   Qadri, Firdausi ^c   Sultana, Shamima ^c   Cravioto, Alejandro ^b,c   Talukder, Kaisar A ^c   Reuteler, Gloria ^a   Brüssow, Harald ^a  

^a NESTLÉ RESEARCH CENTER   (Switzerland)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^c INTERNATIONAL CENTRE FOR DIARRHOEAL DISEASE RESEARCH   (Bangladesh)

Author keywords

[No Author keywords available]

Indexed keywords

BANGLADESH; BIOLOGICAL THERAPY; COLIPHAGES; DIARRHEA; DYSENTERY, BACILLARY; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; HOST SPECIFICITY; HUMANS; MEXICO; SHIGELLA; VIRAL INTERFERENCE;

EID: 84893901905     PISSN: 17517907     EISSN: 17517915     Source Type: Journal    
DOI: 10.1111/1751-7915.12113     Document Type: Article

References (52)

1. Abedon, S.T. (1992) Lysis of lysis-inhibited bacteriophage T4-infected cells. J Bacteriol 174: 8073-8080.
2. Abedon, S.T. (2011) Lysis from without. Bacteriophage 1: 46-49.
3. Albert, M.J., Faruque, S.M., Faruque, A.S.G., Neogi, P.K.B., Ansaruzzaman, M., Bhuiyan, N.A., etal. (1995) Controlled study of Escherichia coli diarrheal infections in Bangladeshi children. J Clin Microbiol 33: 973-977.
4. Albert, M.J., Faruque, A.S., Faruque, S.M., Sack, R.B., and Mahalanabis, D. (1999) Case-control study of enteropathogens associated with childhood diarrhea in Dhaka, Bangladesh. J Clin Microbiol 37: 3458-3464.
5. Browning, D.F., Wells, T.J., França, F.L., Morris, F.C., Sevastsyanovich, Y.R., Bryant, J.A., etal. (2013) Laboratory adapted Escherichia coli K-12 becomes a pathogen of Caenorhabditis elegans upon restoration of O antigen biosynthesis. Mol Microbiol 87: 939-950.
6. Bruttin, A., and Brüssow, H. (2005) Human volunteers receiving Escherichia coli phage T4 orally: a safety test of phage therapy. Antimicrob Agents Chemother 49: 2874-2878.
7. Brüssow, H. (2012) What is needed for phage therapy to become a reality in Western medicine? Virology 434: 138-142.
8. Brüssow, H. (2013) Bacteriophage-host interaction: from splendid isolation into a messy reality. Curr Opin Microbiol 16: 500-506.
9. Cairns, B.J., Timms, A.R., Jansen, V.A., Connerton, I.F., and Payne, R.J. (2009) Quantitative models of in vitro bacteriophage-host dynamics and their application to phage therapy. PLoS Pathog 5: e1000253.
10. Canchaya, C., Proux, C., Fournous, G., Bruttin, A., and Brüssow, H. (2003) Prophage genomics. Microbiol Mol Biol Rev 67: 238-276.
11. Chang, H.W., and Kim, K.H. (2011) Comparative genomic analysis of bacteriophage EP23 infecting Shigella sonnei and Escherichia coli. J Microbiol 49: 927-934.
12. Chanishvili, N. (2012) Phage therapy-history from Twort and d'Herelle through Soviet experience to current approaches. Adv Virus Res 83: 3-40.
13. Chibani-Chennoufi, S., Sidoti, J., Bruttin, A., Kutter, E., Sarker, S., and Brüssow, H. (2004a) In vitro and in vivo bacteriolytic activities of Escherichia coli phages: implications for phage therapy. Antimicrob Agents Chemother 48: 2558-2569.
14. Chibani-Chennoufi, S., Sidoti, J., Bruttin, A., Dillmann, M.L., Kutter, E., Qadri, F., etal. (2004b) Isolation of Escherichia coli bacteriophages from the stool of pediatric diarrhea patients in Bangladesh. J Bacteriol 186: 8287-8294.
15. Chowdhury, F., Rahman, M.A., Begum, Y.A., Khan, A.I., Faruque, A.S., Saha, N.C., etal. (2011) Impact of rapid urbanization on the rates of infection by Vibrio cholerae O1 and enterotoxigenic Escherichia coli in Dhaka, Bangladesh. PLoS Negl Trop Dis 5: e999.
16. Cravioto, A., Reyes, R., Trujillo, F., Uribe, F., Navarro, A., De la Roca, J., etal. (1990) Risk of diarrhea during the first year of life associated with initial and subsequent colonization by specific enteropathogens. Am J Epidemiol 131: 886-904.
17. Doolittle, M.M., Cooney, J.J., and Caldwell, D.E. (1995) Lytic infection of Escherichia coli biofilms by bacteriophage T4. Can J Microbiol 41: 12-18.
18. Doolittle, M.M., Cooney, J.J., and Caldwell, D.E. (1996) Tracing the interaction of bacteriophage with bacterial biofilms using fluorescent and chromogenic probes. J Ind Microbiol 16: 331-341.
19. Flores, C.O., Meyer, J.R., Valverde, S., Farr, L., and Weitz, J.S. (2011) Statistical structure of host-phage interactions. Proc Natl Acad Sci U S A 108: E288-E297.
20. Forde, S.E., Beardmore, R.E., Gudelj, I., Arkin, S.S., Thompson, J.N., and Hurst, L.D. (2008) Understanding the limits to generalizability of experimental evolutionary models. Nature 455: 220-223.
21. Gunzburg, S.T., Tornieporth, N.G., and Riley, L.W. (1995) Identification of enteropathogenic Escherichia coli by PCR-based detection of the bundle-forming pilus gene. J Clin Microbiol 33: 1375.
22. Harris, A.M., Chowdhury, F., Begum, Y.A., Khan, A.I., Faruque, A.S., Svennerholm, A.M., etal. (2008) Shifting prevalence of major diarrheal pathogens in patients seeking hospital care during floods in 1998, 2004, and 2007 in Dhaka, Bangladesh. Am J Trop Med Hyg 79: 708-714.
23. Hashemolhosseini, S., Montag, D., Krämer, L., and Henning, U. (1994) Determinants of receptor specificity of coliphages of the T4 family. A chaperone alters the host range. J Mol Biol 241: 524-533.
24. Heinrichs, D.E., Yethon, J.A., and Whitfield, C. (1998) Molecular basis for structural diversity in the core regions of the lipopolysaccharides of Escherichia coli and Salmonella enterica. Mol Microbiol 30: 221-232.
25. Karch, H., Böhm, H., Schmidt, H., Gunzer, F., Aleksic, S., and Heesemann, J. (1993) Clonal structure and pathogenicity of Shiga-like toxin-producing, sorbitol-fermenting Escherichia coli O157:H. J Clin Microbiol 31: 1200-1205.
26. Kelly, D., McAuliffe, O., Ross, R.P., O'Mahony, J., and Coffey, A. (2011) Development of a broad-host-range phage cocktail for biocontrol. Bioeng Bugs 2: 31-37.
27. McCallin, S.E., Sarker, S.A., Barretto, C., Sultana, S., Berger, B., Huq, S., etal. (2013) Safety analysis of a Russian phage cocktail: from metagenomic analysis to oral application in healthy human subjects. Virology 443: 187-196.
28. McConnell, M.M., Chart, H., Field, H., Hibberd, M., and Rowe, B. (1989) Characterization of a putative colonization factor (PCFO166) of enterotoxigenic Escherichia coli of serogroup O166. J Gen Microbiol 135: 1135-1144.
29. Maura, D., Morello, E., du Merle, L., Bomme, P., Le Bouguénec, C., and Debarbieux, L. (2012a) Intestinal colonization by enteroaggregative Escherichia coli supports long-term bacteriophage replication in mice. Environ Microbiol 14: 1844-1854.
30. Maura, D., Galtier, M., Le Bouguénec, C., and Debarbieux, L. (2012b) Virulent bacteriophages can target O104:H4 enteroaggregative Escherichia coli in the mouse intestine. Antimicrob Agents Chemother 56: 6235-6242.
31. Merril, C.R., Biswas, B., Carlton, R., Jensen, N.C., Creed, G.J., Zullo, S., and Adhya, S. (1996) Long-circulating bacteriophage as antibacterial agents. Proc Natl Acad Sci U S A 93: 3188-3192.
32. Ørskov, F., and Ørskov, I. (1984) Serotyping of Escherichia coli. Meth Microbiol 14: 43-112.
33. Payne, R.J., Phil, D., and Jansen, V.A. (2000) Phage therapy: the peculiar kinetics of self-replicating pharmaceuticals. Clin Pharmacol Ther 68: 225-230.
34. Pollard, D.R., Johnson, W.M., Lior, H., Tyler, S.D., and Rozee, K.R. (1990) Rapid and specific detection of verotoxin genes in Escherichia coli by the polymerase chain reaction. J Clin Microbiol 28: 540-545.
35. Qadri, F., Das, S.K., Faruque, A.S.G., Fuchs, G.J., Albert, M.J., Sack, R.B., and Svennerholm, A.-M. (2000) Prevalence of toxin types and colonization factors in enterotoxigenic Escherichia coli isolated during a 2-year period from diarrheal patients in Bangladesh. J Clin Microbiol 38: 27-31.
36. Qadri, F., Khan, A.I., Faruque, A.S., Begum, Y.A., Chowdhury, F., Nair, G.B., etal. (2005) Enterotoxigenic Escherichia coli and Vibrio cholerae diarrhea, Bangladesh, 2004. Emerg Infect Dis 11: 1104-1107.
37. Qadri, F., Saha, A., Ahmed, T., Al Tarique, A., Begum, Y.A., and Svennerholm, A.M. (2007) Disease burden due to enterotoxigenic Escherichia coli in the first 2 years of life in an urban community in Bangladesh. Infect Immun 75: 3961-3968.
38. Qimron, U., Marintcheva, B., Tabor, S., and Richardson, C.C. (2006) Genomewide screens for Escherichia coli genes affecting growth of T7 bacteriophage. Proc Natl Acad Sci U S A 103: 19039-19044.
39. Robins-Browne, R.M. (1987) Traditional enteropathogenic Escherichia coli of infantile diarrhea. Rev Infect Dis 9: 28-53.
40. Santos, S.B., Fernandes, E., Carvalho, C.M., Sillankorva, S., Krylov, V.N., Pleteneva, E.A., etal. (2010) Selection and characterization of a multivalent Salmonella phage and its production in a nonpathogenic Escherichia coli strain. Appl Environ Microbiol 76: 7338-7342.
41. Sarker, S.A., McCallin, S., Barretto, C., Berger, B., Pittet, A.C., Sultana, S., etal. (2012) Oral T4-like phage cocktail application to healthy adult volunteers from Bangladesh. Virology 434: 222-232.
42. Schultsz, C., Pool, G.J., van Ketel, R., de Wever, B., Speelman, P., and Dankert, J. (1994) Detection of enterotoxigenic Escherichia coli in stool samples by using nonradioactively labeled oligonucleotide DNA probes and PCR. J Clin Microbiol 32: 2393-2397.
43. Schwarzer, D., Buettner, F.F., Browning, C., Nazarov, S., Rabsch, W., Bethe, A., etal. (2012) A multivalent adsorption apparatus explains the broad host range of phage phi92: a comprehensive genomic and structural analysis. J Virol 86: 10384-10398.
44. Sims, G.E., and Kim, S.H. (2011) Whole-genome phylogeny of Escherichia coli/Shigella group by feature frequency profiles (FFPs). Proc Natl Acad Sci U S A 108: 8329-8334.
45. Sulakvelidze, A., Alavidze, Z., and Morris, J.G., Jr (2001) Bacteriophage therapy. Antimicrob Agents Chemother 45: 649-659.
46. Svennerholm, A.-M., and Wiklund, G. (1983) Rapid GM1-enzyme-linked immunosorbent assay with visual reading for identification of Escherichia coli heat-labile enterotoxin. J Clin Microbiol 17: 596-600.
47. Svennerholm, A.M., Wikström, M., Lindblad, M., and Holmgren, J. (1986) Monoclonal antibodies against Escherichia coli heat-stable toxin (STa) and their use in a diagnostic ST ganglioside GM1-enzyme-linked immunosorbent assay. J Clin Microbiol 24: 585-590.
48. Tamaki, S., Sato, T., and Matsuhashi, M. (1971) Role of lipopolysaccharides in antibiotic resistance and bacteriophage adsorption of Escherichia coli K-12. J Bacteriol 105: 968-975.
49. Thomassen, E., Gielen, G., Schütz, M., Schoehn, G., Abrahams, J.P., Miller, S., and van Raaij, M.J. (2003) The structure of the receptor-binding domain of the bacteriophage T4 short tail fibre reveals a knitted trimeric metal-binding fold. J Mol Biol 331: 361-373.
50. Weiss, M., Denou, E., Bruttin, A., Serra-Moreno, R., Dillmann, M.L., and Brüssow, H. (2009) In vivo replication of T4 and T7 bacteriophages in germ-free mice colonized with Escherichia coli. Virology 393: 16-23.
51. Weitz, J.S., Poisot, T., Meyer, J.R., Flores, C.O., Valverde, S., Sullivan, M.B., and Hochberg, M.E. (2013) Phage-bacteria infection networks. Trends Microbiol 21: 82-91.
52. Yu, S.L., Ko, K.L., Chen, C.S., Chang, Y.C., and Syu, W.J. (2000) Characterization of the distal tail fiber locus and determination of the receptor for phage AR1, which specifically infects Escherichia coli O157:H7. J Bacteriol 182: 5962-5968.